|
Latest Reports
|
| Date |
Description |
Country |
Analyst |
Download |
|
|
| 10-Feb-2024 |
Zydus Lifesciences Ltd - Margin surprised +vely; Robust 4Q likely; Maintain BUY with raised TP Rs 880 |
India |
Surya Patra |
 |
| 18-May-2023 |
Zydus Lifesciences - Strong show in core operating performance; Maintain BUY with raised TP of Rs 600 |
India |
Surya Patra |
|
| 05-Feb-2023 |
Zydus Lifesciences Ltd - Steady improvement in core operations; Maintain BUy with TP Rs 530 |
India |
Surya Patra |
|
| 14-Nov-2022 |
Zydus Lifesciences Ltd - Improved domestic & gRevlimid drives value growth; BUY with raised TP of Rs 530 |
India |
Surya Patra |
|
| 11-Aug-2022 |
Zydus Lifesciences - Paints stable outlook amidst challenges; Maintain BUY with lowered TP of Rs 450 |
India |
Surya Patra |
|
| 22-May-2022 |
Zydus Lifesciences Ltd - US pricing challenge hurts FY23 growth ; Maintain BUY with lowered TP Rs 470 |
India |
Surya Patra |
|
| 04-Feb-2022 |
Cadila Healthcare - Covid vaccine opportunity seems vanished; Maintain BUY with lowered TP Rs 500 |
India |
Surya Patra |
|
| 01-Nov-2021 |
Cadila Healthcare - Covid vaccine to power earnings & competition in Asacol HD is not a big concern: Buy with lowered TP Rs 640 |
India |
Surya Patra |
|
| 23-Aug-2021 |
Cadila Healthcare - Covid vaccine is a multi-year opportunity: BUY with TP Rs 680 |
India |
Surya Patra |
|
| 11-Aug-2021 |
Cadila Healthcare - Covid vaccine to power earnings ahead: Maintain BUY with TP Rs 680 |
India |
Surya Patra |
|
| 28-May-2021 |
Cadila Healthcare - Robust visible earnings to drive re-rating; BUY with raised TP of Rs 770 |
India |
Surya Patra |
|
| 14-May-2021 |
Cadila Healthcare - All moves towards qualitative earnings upgrade:; BUY with raised TP Rs 665 |
India |
Surya Patra |
|
| 07-Feb-2021 |
Cadila Healthcare (CDH IN) - Strong value growth visibility remains intact ; Maintain BUY with TP Rs 600 |
India |
Surya Patra |
|
| 03-Nov-2020 |
Cadila Healthcare - Reported robust Q2 and set to show even stronger H2: BUY with TP Rs 550 |
India |
Surya Patra |
|
| 13-Oct-2020 |
Cadila Healthcare - Innovation-led growth on all fronts; BUY with TP Rs 550 and potential upside from Covid portfolio further |
India |
Surya Patra |
|
| 06-Aug-2020 |
Cadila Healthcare - Faster profitable growth ahead; BUY with TP Rs 450 |
India |
Surya Patra |
|
| 21-Jun-2020 |
Cadila Healthcare - Steady profitable growth ahead; Maintain BUY with TP Rs 400 |
India |
Surya Patra |
|
| 07-Feb-2020 |
Cadila Healthcare (CDH IN) : Set for a steady growth |
India |
Surya Patra |
|
| 14-Nov-2019 |
Cadila Healthcare - Negatives priced in; Maintain BUY with TP Rs 320 |
India |
Surya Patra |
|
| 13-Aug-2019 |
Cadila Healthcare (CDH IN) - Growth outlook is weaker but priced-in; BUY with TP Rs 320 |
India |
Surya Patra |
|
| 30-May-2019 |
Cadila Healthcare (CDH IN) - Missed estimates, but priced attractively; BUY with TP Rs 400 |
India |
Surya Patra |
|
| 08-Feb-2019 |
Cadila Healthcare (CDH IN) - Stable growth in US/India business to drive value growth; BUY with TP of Rs 440 |
India |
Surya Patra |
|
| 04-Nov-2018 |
Cadila Healthcare - Foresees steady progress despite market challenges: Maintain BUY with TP Rs 415 |
India |
Surya Patra |
|
| 13-Aug-2018 |
Cadila Healthcare - Powered by exclusive opportunity in Asacol HD; Upgrade to BUY with TP Rs 415 |
India |
Surya Patra |
|
| 28-May-2018 |
Cadila Healthcare -Stable outlook for US but cautious on margins; NEUTRAL with TP of Rs 430 |
India |
Surya Patra |
|
|
|